Gabrielle Macaron

485 total citations
28 papers, 301 citations indexed

About

Gabrielle Macaron is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Gabrielle Macaron has authored 28 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Gabrielle Macaron's work include Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (5 papers) and RNA regulation and disease (4 papers). Gabrielle Macaron is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (5 papers) and RNA regulation and disease (4 papers). Gabrielle Macaron collaborates with scholars based in United States, Lebanon and Canada. Gabrielle Macaron's co-authors include Daniel Ontaneda, Mary Rensel, Jeffrey A. Cohen, Sami Richa, Manikum Moodley, Brandon Moss, Stephen M. Rao, Laura Baldassari, Nathalie Arbour and Catherine Larochelle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The Lancet Neurology.

In The Last Decade

Gabrielle Macaron

25 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabrielle Macaron United States 10 200 77 45 38 37 28 301
Salvatore Cottone Italy 9 199 1.0× 102 1.3× 37 0.8× 47 1.2× 25 0.7× 24 333
José Meca-Lallana Spain 12 242 1.2× 86 1.1× 30 0.7× 40 1.1× 43 1.2× 43 325
Verónica Rivas‐Alonso Mexico 9 151 0.8× 137 1.8× 22 0.5× 35 0.9× 64 1.7× 29 290
Martina Petruzzo Italy 10 215 1.1× 77 1.0× 16 0.4× 37 1.0× 17 0.5× 16 295
Mar Mendibe Bilbao Spain 9 147 0.7× 62 0.8× 25 0.6× 42 1.1× 19 0.5× 18 210
Reza Vosoughi Canada 9 194 1.0× 107 1.4× 52 1.2× 55 1.4× 27 0.7× 22 354
Espen Benjaminsen Norway 11 201 1.0× 77 1.0× 20 0.4× 39 1.0× 48 1.3× 20 324
Cecilia Smith Simonsen Norway 9 309 1.5× 105 1.4× 27 0.6× 79 2.1× 81 2.2× 18 380
Nik Krajnc Austria 11 178 0.9× 162 2.1× 33 0.7× 40 1.1× 18 0.5× 49 313
Élaine Roger Canada 11 215 1.1× 45 0.6× 20 0.4× 43 1.1× 69 1.9× 20 318

Countries citing papers authored by Gabrielle Macaron

Since Specialization
Citations

This map shows the geographic impact of Gabrielle Macaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Macaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Macaron more than expected).

Fields of papers citing papers by Gabrielle Macaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Macaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Macaron. The network helps show where Gabrielle Macaron may publish in the future.

Co-authorship network of co-authors of Gabrielle Macaron

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Macaron. A scholar is included among the top collaborators of Gabrielle Macaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Macaron. Gabrielle Macaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giacomini, Paul S., et al.. (2026). Eye tracking as a digital biomarker in neurodegenerative diseases. Journal of Neurology. 273(2). 133–133.
2.
Mrabet, Saloua, et al.. (2025). Multiple Sclerosis in the Middle East and North Africa: Perspectives and Challenges. International Journal of MS Care. T21–T21. 1 indexed citations
3.
Desu, Haritha L., Audrey Daigneault, Wendy Klément, et al.. (2025). Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment. EBioMedicine. 112. 105559–105559. 1 indexed citations
4.
Macaron, Gabrielle, Nadine Farah, Simon Charbonneau, et al.. (2025). Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor. Multiple Sclerosis Journal. 31(8). 896–904. 1 indexed citations
5.
Amin, Moein, et al.. (2024). Discordance of reported multiple sclerosis clinical course amongst patients and providers. Journal of Neuroimmunology. 395. 578443–578443. 1 indexed citations
6.
Macaron, Gabrielle, et al.. (2023). Impact of aging on treatment considerations for multiple sclerosis patients. Frontiers in Neurology. 14. 1197212–1197212. 25 indexed citations
7.
Haddad, Sara F., et al.. (2023). High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(1). 3090512111–3090512111. 2 indexed citations
8.
Amin, Moein, et al.. (2023). Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple Sclerosis. International Journal of MS Care. 26(3). 91–97. 3 indexed citations
9.
Macaron, Gabrielle, et al.. (2023). Biomarkers in multiple sclerosis: An update. SHILAP Revista de lepidopterología. 9. 100075–100075.
11.
Macaron, Gabrielle, et al.. (2022). Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence. Patient Preference and Adherence. Volume 16. 1307–1319. 6 indexed citations
12.
Galioto, Rachel, Gabrielle Macaron, John W. Lace, Daniel Ontaneda, & Stephen M. Rao. (2021). Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?. Multiple Sclerosis and Related Disorders. 54. 103106–103106. 10 indexed citations
13.
Nadjar, Yann, et al.. (2021). Adult-onset Genetic Leukodystrophies Misdiagnosed as Multiple Sclerosis in Clinical Practice (1617). Neurology. 96(15_supplement). 1 indexed citations
14.
Macaron, Gabrielle, et al.. (2020). Safety of Newer Disease Modifying Therapies in Multiple Sclerosis. Vaccines. 9(1). 12–12. 30 indexed citations
15.
Abboud, Hesham, et al.. (2019). Defining the spectrum of spasticity-associated involuntary movements. Parkinsonism & Related Disorders. 65. 79–85. 5 indexed citations
16.
Baldassari, Laura, Kunio Nakamura, Brandon Moss, et al.. (2019). Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice. Multiple Sclerosis and Related Disorders. 38. 101525–101525. 15 indexed citations
17.
Macaron, Gabrielle, et al.. (2019). Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis. Current Treatment Options in Neurology. 21(10). 50–50. 23 indexed citations
18.
Macaron, Gabrielle & Jeffrey A. Cohen. (2018). Integrating multiple sclerosis guidelines into practice. The Lancet Neurology. 17(8). 658–660. 6 indexed citations
19.
Khaled, Karine Abou, Jean Khoury, Gabrielle Macaron, & Sami Richa. (2016). Forced normalization and psychosis following use of lacosamide. Seizure. 41. 96–99. 8 indexed citations
20.
Macaron, Gabrielle, et al.. (2013). Anxiety, Depression and Suicidal Ideation in Lebanese Patients Undergoing Hemodialysis. Community Mental Health Journal. 50(2). 235–238. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026